The effects of arctigenin on human rheumatoid arthritis fibroblast-like synoviocytes

References

• Arnett FC, Edworthy SM, Bloch DA, et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–24
   PubMed Web of Science ®Google Scholar
• Aupperle KR, Bennett BL, Boyle DL, et al. (1999). NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol 163:427–33
   PubMed Web of Science ®Google Scholar
• Aupperle KR, Boyle DL, Hendrix M, et al. (1998). Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 152:1091–8
   PubMedGoogle Scholar
• Awale S, Lu J, Kalauni SK, et al. (2006). Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res 66:1751–7
   PubMed Web of Science ®Google Scholar
• Bartok B, Firestein GS. (2010). Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol Rev 233:233–55
   PubMed Web of Science ®Google Scholar
• Cho MK, Jang YP, Kim YC, Kim SG. (2004). Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent KK inhibition: The role in TNF-alpha inhibition. Int Immunopharmacol 4:1419–29
   PubMed Web of Science ®Google Scholar
• Elmore S. (2007). Apoptosis: A review of programmed cell death. Toxicol Pathol 35:495–516
   PubMed Web of Science ®Google Scholar
• Firestein GS. (2003). Evolving concepts of rheumatoid arthritis. Nature 423:356–61
   PubMed Web of Science ®Google Scholar
• Firestein GS, Echeverri F, Yeo M, et al. (1997). Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 94:10895–900
   PubMed Web of Science ®Google Scholar
• Franz JK, Pap T, Hummel KM, et al. (2000). Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 43:599–607
   PubMedGoogle Scholar
• García S, Liz M, Gómez-Reino JJ, Conde C. (2010). Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of bid cleavage. Arthritis Res Ther 12:R33
   PubMed Web of Science ®Google Scholar
• García-Sáez AJ. (2012). The secrets of the Bcl-2 family. Cell Death Differ 19:1733–40
   PubMed Web of Science ®Google Scholar
• Holetz FB, Pessini GL, Sanches NR, et al. (2002). Screening of some plants used in the Brazilian folk medicine for the treatment of infectious diseases. Mem Inst Oswaldo Cruz 97:1027–31
   PubMed Web of Science ®Google Scholar
• Hsieh CJ, Kuo PL, Hsu YC, et al. (2014). Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation. Free Radic Biol Med 67:159–70
   PubMed Web of Science ®Google Scholar
• Huang K, Li LA, Meng YG, et al. (2014). Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling. Basic Clin Pharmacol Toxicol 115:507--11, doi: 10.1111/bcpt.12270
   PubMedGoogle Scholar
• Huber LC, Distler O, Tarner I, et al. (2006). Synovial fibroblasts: Key players in rheumatoid arthritis. Rheumatology 45:669–75
   PubMed Web of Science ®Google Scholar
• Kuida K, Haydar TF, Kuan CY, et al. (1998). Reduced apoptosis and cytochrome C-mediated caspase activation in mice lacking caspase 9. Cell 94:325–37
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim CJ. (2010). Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits type I-IV allergic inflammation and pro-inflammatory enzymes. Arch Pharm Res 33:947–57
   PubMed Web of Science ®Google Scholar
• Makarov SS. (2001). NF-kappa B in rheumatoid arthritis: A pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res 3:200–6
   PubMedGoogle Scholar
• Martin SJ, Reutelingsperger CP, McGahon AJ, et al. (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545–56
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Hosono-Nishiyama K, Yamada H. (2006). Antiproliferative and apoptotic effects of butyrolactone lignans from Arctium lappa on leukemic cells. Planta Med 72:276–8
   PubMed Web of Science ®Google Scholar
• Morel J, Audo R, Hahne M, Combe B. (2005). Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem 280:15709–18
   PubMed Web of Science ®Google Scholar
• Pattacini L, Boiardi L, Casali B, Salvarani C. (2010). Differential effects of anti-TNF-alpha drugs on fibroblast-like synoviocyte apoptosis. Rheumatology (Oxford) 49:480–9
   PubMedGoogle Scholar
• Perelman A, Wachtel C, Cohen M, et al. (2012). JC-1: Alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis 3:e430
   PubMed Web of Science ®Google Scholar
• Perlman H, Georganas C, Pagliari LJ, et al. (2000). Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 164:5227–35
   PubMed Web of Science ®Google Scholar
• Rao L, White E. (1997). Bcl-2 and the ICE family of apoptotic regulators: Making a connection. Curr Opin Genet Dev 7:52–8
   PubMed Web of Science ®Google Scholar
• Rinkenberger JL, Korsmeyer SJ. (1997). Errors of homeostasis and deregulated apoptosis. Curr Opin Genet Dev 7:589–96
   PubMedGoogle Scholar
• Schedel J, Gay RE, Kuenzler P, et al. (2002). FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum 46:1512–8
   PubMedGoogle Scholar
• Sun S, Wang X, Wang C, et al. (2011). Arctigenin suppresses unfolded protein response and sensitizes glucose deprivationmediated cytotoxicity of cancer cells. Planta Med 77:141–5
   PubMedGoogle Scholar
• Susanti S, Iwasaki H, Itokazu Y, et al. (2012). Tumor specific cytotoxicity of arctigenin isolated from herbal plant Arctium lappa L. J Nat Med 66:614–21
   PubMed Web of Science ®Google Scholar
• Vyssokikh MY, Zorova L, Zorov D, et al. (2002). Bax releases cytochrome c preferentially from a complex between porin and adenine nucleotide translocator. Hexokinase activity suppresses this effect. Mol Biol Rep 29:93–6
   PubMedGoogle Scholar
• Wang HQ, Jin JJ, Wang J. (2014). Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression. J Biochem Mol Toxicol 28:39–45
   PubMedGoogle Scholar
• Yang S, Ma J, Xiao J, et al. (2012). Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis. Anat Rec (Hoboken) 295:1260–6
   PubMedGoogle Scholar
• Yao X, Zhu F, Zhao Z, et al. (2011). Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway. J Cell Biochem 112:2837–49
   PubMedGoogle Scholar
• Zhao F, Wang L, Liu K. (2009). In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. J Ethnopharmacol 122:457–62
   PubMed Web of Science ®Google Scholar